209 Items, 11 Pages <<Prev 2 3 4 5 6 7 8 9 10 11 Next>> All
No. | Name of Lifestyle | Third Class | Second Class | First Class | Type | No. of Studies |
---|---|---|---|---|---|---|
161 | pregnen-diol disulfate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
162 | Previous Cardiovascular disease | Cardiovascular disease(CVD) | Diseases | Clinical characteristics | No statistical significance factor | 1 |
163 | propionylcarnitine | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
164 | Prostate diseases | Prostate diseases | Diseases | Clinical characteristics | Risk factor | 1 |
165 | Prostatitis | Prostate diseases | Diseases | Clinical characteristics | Risk factor No statistical significance factor | 7 |
166 | PSA | PSA | Biochemical examination | Clinical characteristics | Risk factor No statistical significance factor | 3 |
167 | Pulse | Pulse | Biochemical examination | Clinical characteristics | No statistical significance factor | 2 |
168 | Pulses | Pulse | Biochemical examination | Clinical characteristics | Risk factor | 1 |
169 | Random blood glucose | Blood glucose | Biochemical examination | Clinical characteristics | No statistical significance factor | 1 |
170 | Ribose | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
171 | Screened | Screen | Accessory examination | Clinical characteristics | Protective factor | 1 |
172 | Self-reportedacne | Acne | Diseases | Clinical characteristics | No statistical significance factor | 1 |
173 | Serum creatinine | Serum creatinine | Biochemical examination | Clinical characteristics | Risk factor No statistical significance factor | 1 |
174 | Sphinganine | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
175 | Statin | Statin | Drug | Clinical characteristics | Protective factor No statistical significance factor | 4 |
176 | Statin dose | Statin | Drug | Clinical characteristics | No statistical significance factor | 1 |
177 | Statin type | Statin | Drug | Clinical characteristics | Protective factor No statistical significance factor | 1 |
178 | stearate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
179 | Subcutaneous fat area | Fat area | Biochemical examination | Clinical characteristics | Reference | 1 |
180 | Sulphonylurea | Antidiabetic | Drug | Clinical characteristics | No statistical significance factor | 1 |